MDM2 and gastric cancer: Yao et al. [41] demonstrated that higher SPRR2B levels in gastric cancer (GC) tissues correlate significantly with advanced tumor size, stage, and poorer survival, implicating SPRR2B in GC progression through the MDM2-p53/p21 pathway.